Home
About Us
About Us
Board of Directors
Scientific Advisory Board
Management Team
Careers
For Researchers
Paxalisib
EVT801
Collaborating with Kazia
Publications and Presentations
For Partners
Our Current Partners
What We Are Looking For
For Patients
Accessing Kazia Drug Candidates in Clinical Trials
Accessing Kazia Drug Candidates for Compassionate Use
Resources for Patients
For Investors
Press Releases
ASX Announcements
Delisting from ASX
SEC Filings
Corporate Presentations
Annual Reports
Financial Reports
AGM
Investor Newsletters
Corporate Governance
Shareholder Services
Media Centre
Overview
Video
Coverage
Contact
Contact Us
Subscribe to email alerts
Heading &
Sub-heading can be edited through HQI
Home
>
Media Centre
>
Video
Overview
Video
Coverage
Video
20-May-2021
Edison TV: Kazia Therapeutics - overview and update with CEO James Garner
9-Feb-2021
Kazia Therapeutics with Proactive at the ASX Small and Mid Cap Conference
9-Apr-2020
Kazia CEO, Dr James Garner discusses the recent positive interim data from the phase II trial of paxalisib in glioblastoma, COVID-19 and the company's recent capital raising
26-Jun-2019
Kazia’s CEO Dr James Garner presented an overview of the company as a guest speaker at the 2019 Gold Coast Investment Showcase
15-Apr-2019
Kazia’s CEO Dr James Garner presented an overview of the company as a guest speaker at the Wholesale Investor Emergence event in Brisbane
11-Jul-2018
Kazia’s CEO Dr James Garner presented an overview of the company as a guest speaker at the 2018 Gold Coast Investment Showcase
6-Apr-2018
Dr James Garner speaks with CommSec re our GDC-0084 Phase II trial start
29-Mar-2018
NDF Research Senior Analyst Stuart Roberts interviews Kazia Therapeutics CEO Dr James Garner as the GDC-0084 phase II trial launches in the US
30-Nov-2017
CommSec interview re our new name, Kazia Therapeutics and our clinical trial progress
4-Jul-2017
CommSec Executive Series interviews CEO Dr James Garner on benefits of new business model for patients
Previous
1
2
3
4
Next
